Unique Ingredient Identifier 45P3261C7T is listed as a ingredient substance
| RN | 497-19-8 |
| EC | 207-838-8 |
| NCIT | C47721 |
| RXCUI | 36685 |
| PUBCHEM | 10340 |
| MF | CO3.2Na |
| INCHI KEY | CDBYLPFSWZWCQE-UHFFFAOYSA-L |
| SMILES | [Na+].[Na+].[O-]C([O-])=O |
UNII 45P3261C7T SODIUM CARBONATE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AN,INFILTRATION | INJECTION | ADJPH |
| BUCCAL | GUM | 14.4 MG |
| BUCCAL | GUM, CHEWING | 30 MG |
| BUCCAL | TABLET | 20 MG |
| IM - IV | INJECTION | 1.64 % |
| IM - IV | POWDER, FOR INJECTION SOLUTION | 63 % |
| INTRA-ARTERIAL | SOLUTION, INJECTION | ADJPH |
| INTRAMUSCULAR | INJECTION | 1 % |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION | NA |
| INTRAPERITONEAL | POWDER, FOR INJECTION SOLUTION | NA |
| INTRAPLEURAL | POWDER, FOR INJECTION SOLUTION | NA |
| INTRATUMOR | POWDER, FOR INJECTION SOLUTION | NA |
| INTRAVASCULAR | INJECTION | ADJPH |
| INTRAVASCULAR | SOLUTION, INJECTION | ADJPH |
| INTRAVENOUS | INJECTION | 15.4 %W/W |
| INTRAVENOUS | POWDER | 575 MG |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 20.8 % |
| INTRAVENOUS | SOLUTION, INJECTION | ADJPH |
| IV - SC | INJECTION | ADJPH |
| IV(INFUSION) | INJECTION | 24.1 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.18 % |
| NERVE BLOCK | INJECTION | ADJPH |
| OPHTHALMIC | SOLUTION | 0.01 % |
| ORAL | CAPSULE | 91.8 MG |
| ORAL | CAPSULE, DELAYED ACTION | 10 mg |
| ORAL | CAPSULE, SUSTAINED ACTION | 6 MG |
| ORAL | GRANULE, FOR ORAL SUSPENSION | 6.5 MG |
| ORAL | GUM, CHEWING | 10 MG |
| ORAL | INJECTION | 2.4 %W/V |
| ORAL | LOZENGE | 25 mg |
| ORAL | SUSPENSION, SUSTAINED ACTION | 6.5 MG/206.84 MG |
| ORAL | TABLET | 10.4 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 8 MG |
| ORAL | TABLET, DELAYED ACTION | 15 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 10 MG |
| ORAL | TABLET, EFFERVESCENT, FOR SOLUTION | 430 MG |
| ORAL | TABLET, EXTENDED RELEASE | 30 MG |
| ORAL | TABLET, FILM COATED | 30 MG |
| ORAL | TABLET, UNCOATED, LOZENGE | 8.55 MG |
| ORAL | TROCHE | 25 MG |
| RECTAL | POWDER, FOR INJECTION SOLUTION | NA |
| RECTAL | SUSPENSION | NA |
| SUBLINGUAL | TABLET | 7.5 MG |